Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank75
3Y CAGR+14.6%
5Y CAGR+1.5%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+14.6%/yr
Annual compound
5Y CAGR
+1.5%/yr
Recent acceleration
Percentile
P75
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.50M | -72.6% |
| 2024 | $9.11M | +126.6% |
| 2023 | $4.02M | +142.2% |
| 2022 | $1.66M | +30.0% |
| 2021 | $1.28M | -44.9% |
| 2020 | $2.32M | +139.1% |
| 2019 | $-5.93M | -21848.1% |
| 2018 | $-27000.00 | +94.4% |
| 2017 | $-483000.00 | - |